ArticleCureus2025
Red Blood Cell Distribution Width (RDW) Is a Potential Surrogate Biomarker of Inflammation in Patients With Achalasia: A Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Current studies demonstrate that red blood cell distribution width (RDW) is a potential surrogate biomarker of inflammation. This study aims to compare the RDW and RDW/lymphocytes ratio in patients with achalasia who underwent five-year postoperative follow-up with those in the gastroesophageal reflux disease (GERD) and healthy donor groups, and to evaluate their clinical relevance in relation to integrated relaxation pressure (IRP), sex, inflammation and the type of achalasia (fibrosis). Materials and methods This was a retrospective study with a five-year follow-up. One hundred sixty-one patients with achalasia, 161 patients with GERD and 500 healthy donors (HD) were included and followed up for five years. The achalasia and GERD patient groups were matched with the HD control group based on demographic characteristics and laboratory variables. The diagnoses of achalasia and GERD were made using high-resolution esophageal manometry, upper gastrointestinal endoscopy, barium esophagography, and 24-hour pH monitoring. For the achalasia group, the correlation between RDW and clinical characteristics, including Eckardt score, Eat Assessment Tool (EAT-10) score, the GERD-Related Quality of Life (GERD-HRQL) questionnaire score, achalasia type, sex, comorbidities, and integrated relaxation pressure, was evaluated using logistic regression analysis. Results The RDW values at baseline differed significantly between patients (achalasia and those with GERD) and HD (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.